Fig. 3From: Correction to: Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulationsMost active compound (IC50 = 0.2) mapped to all the featuresBack to article page